Marker Therapeutics (MRKR) Earnings Date & Reports

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications... Show more

Industry: #Other Consumer Services

Get AI intraday signals

A.I. Advisor

published Earnings

MRKR is expected to report earnings to rise 35.62% to -21 cents per share on August 13

Marker Therapeutics MRKR Stock Earnings Reports

Q2'26

Est.

$-0.22

Q1'26

Beat

by $0.06

Q4'25

Beat

by $0.68

Q3'25

Beat

by $0.50

Q2'25

Beat

by $0.19

The last earnings report on May 20 showed earnings per share of -15 cents, beating the estimate of -21 cents. With 251.00 shares outstanding, the current market capitalization sits at 22.84M.

View a ticker or compare two or three

Compare

MRKR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for MRKR